126 results
8-K
BIVI
BioVie Inc - Ordinary Shares
19 Apr 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:15pm
litigation, changes in local or national economic conditions as well as various additional risks, many of which are now unknown and generally out
8-K
EX-99.1
BIVI
BioVie Inc - Ordinary Shares
11 Mar 24
BioVie Announces Pipeline Update and Near-Term Clinical Priorities
5:00pm
approval for our product candidates, our ability to successfully defend potential future litigation, changes in local or national economic conditions as well
8-K
BIVI
BioVie Inc - Ordinary Shares
11 Mar 24
BioVie Announces Pipeline Update and Near-Term Clinical Priorities
5:00pm
potential future litigation, changes in local or national economic conditions as well as various additional risks, many of which are now unknown
8-K
EX-99.1
BIVI
BioVie Inc - Ordinary Shares
6 Mar 24
BioVie Inc. Announces Closing of Public Offering
5:10pm
defend potential future litigation, changes in local or national economic conditions as well as various additional risks, many of which are now
424B5
8sf0gooc nea5ns
4 Mar 24
Prospectus supplement for primary offering
5:28pm
8-K
EX-99.1
7ccil
4 Mar 24
BioVie Inc. Announces Proposed Public Offering of Common Stock
7:50am
8-K
EX-10.1
1wyz71cob
4 Mar 24
BioVie Inc. Announces Proposed Public Offering of Common Stock
7:50am
8-K
EX-99.2
cb91knicwcjecajpwiz
4 Mar 24
BioVie Inc. Announces Proposed Public Offering of Common Stock
7:50am
424B5
r1z0p9rjqwo6
1 Mar 24
Prospectus supplement for primary offering
5:27pm
8-K
EX-99.1
vnn055e9
1 Mar 24
Other Events
9:40am
8-K
6yg43da sf2brq12e2
1 Mar 24
Other Events
9:40am
8-K
yjwqipwsdwku55z
25 Jan 24
Other Events
5:00pm
8-K
EX-99.1
1yhp4
29 Nov 23
BioVie Announces EfficacyData from Phase 3 Trial of NE3107 in Patientswith Mild to Moderate Alzheimer’s Disease
8:20am
8-K
EX-99.1
qoc4o wnmgca
25 Oct 23
Other Events
1:04pm
8-K
sf1d4ufx pu6
25 Oct 23
Other Events
1:04pm